Equine Sports Council

Controlled Medications Library

ESC MEDICATION CLASSIFICATIONClass B - Strictly Controlled - PE Potential

ESC Medication Library · Revision 2

← Medication library · Compare sanctioning bodies

Phenprocoumon

Medication Facts

Performance enhancing
No
Total hours to clear
Not recorded
Frequently used
N/A
ESC ID
PHENPR-0710
Trade names
Not recorded
Drug type
Anticoagulant
Plasma half-life · hours
6
Equine dosing
Consult Veterinarian
Cmax · peak plasma concentration
Unavailable
Tmax · time to peak plasma concentration
18
ESC concentration guidance
May not exceed 6% efficacy in plasma
Primary withdrawal · hours
12
Washout withdrawal · hours
0
ESC control type
B1 - Strictly Controlled - Conditionally PE
Medication report required
MED REPORT REQUIRED

Uses & side effects

Product-specific side effects await source review.

Drug interactions

Anticoagulant and antiplatelet medications in horses interact most severely with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and other clotting-altering agents, drastically escalating the risk of life-threatening gastrointestinal hemorrhage or internal bleeding. Anticoagulants (like heparin and historical use of warfarin) and antiplatelets (like aspirin and clopidogrel) are utilized in equine medicine to prevent or treat laminitis, jugular thrombophlebitis, disseminated intravascular coagulation (DIC), and endotoxemia. Because horses are naturally prone to gastric ulcers and colon issues, combining therapies that compromise clotting and mucosal protection demands extreme caution.The primary drug-to-drug interactions for equine anticoagulants and antiplatelets include:1. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)Medications: Phenylbutazone (“Bute”), Flunixin Meglumine (“Banamine”), Firocoxib (Equioxx).The Interaction: Severe pharmacodynamic interaction. NSAIDs inhibit cyclooxygenase (COX) enzymes, which diminishes the production of protective prostaglandins in the horse's gut and kidneys. Concurrently, they temporarily disrupt blood platelet function.Clinical Impact: Critical risk. When stacked with an anticoagulant like heparin, the protective lining of the gastrointestinal tract weakens while the blood's ability to clot is suppressed. This combination frequently causes severe, life-threatening gastrointestinal bleeding, bleeding into joints, or internal bleeding from injection sites.2. Multi-Agent Antithrombotic StackingMedications: Combining Heparin (Unfractionated or Low-Molecular-Weight) with Aspirin or Clopidogrel.The Interaction: Dual antiplatelet/anticoagulant therapy over-suppresses different pathways of the clotting cascade (e.g., heparin inactivates thrombin, while clopidogrel blocks platelet P2Y12 receptors).Clinical Impact: High risk. While sometimes intentionally utilized in critical hospital settings for severe jugular thrombosis, it creates a narrow therapeutic window. The slightest trauma can cause severe, uncontrolled hematomas or continuous bleeding.3. Heparin and Protamine Sulfate (Antagonism)Medications: Protamine Sulfate.The Interaction: Direct chemical neutralization. Protamine is a strongly basic protein that binds directly to strongly acidic heparin molecules, creating a stable, inactive salt complex.Clinical Impact: While technically an interaction, this is highly beneficial. Protamine acts as the specific antidote to reverse heparin overdose or treat severe hemorrhage induced by heparin therapy.4. Cytochrome P450 Modulators (with Clopidogrel or Warfarin)Medications: Cimetidine, Omeprazole, certain Macrolide antibiotics.The Interaction: Antiplatelets like clopidogrel are prodrugs that require activation by hepatic cytochrome P450 enzymes to become effective. Conversely, historical oral anticoagulants like warfarin are broken down by these same liver enzymes.Clinical Impact: Moderate to High.If a horse receives an enzyme inhibitor (like cimetidine) alongside clopidogrel, the horse will fail to activate the drug, rendering the anti-clotting therapy useless.If a horse is on warfarin, enzyme inhibitors can trigger a rapid, toxic accumulation of the anticoagulant, inducing spontaneous systemic bleeding.

Contraindications

Sanctioning-body comparison

Plasma only. Compare published competition guidance for this medication. ESC guidance remains in Medication Facts above. A dosing guideline, withdrawal recommendation and laboratory detection threshold are different measures.

Sources reviewed September 23, 2026. “Not verified” means a gap in this comparison, not zero tolerance or permission. Doses describe the cited rules; your veterinarian must determine treatment and withdrawal.

Published guidance by organization
OrganizationPublished dose & routePlasma concentrationWithdrawal / timingControl / penalty class
AQHA Show HorsesShow rules · 2026 handbook
Conditions & sources

An unverified entry is not permission to use this medication. Consult the linked current rules.

Reviewed 2026-09-23

Not verified for this medication.Not verified for this medication.Not verified for this medication.Medication-specific control not yet verified.
APHA Paint Show HorsesShow rules · 2026 Rule Book
Conditions & sources

An unverified entry is not permission to use this medication. Consult the linked current rules.

Reviewed 2026-09-23

Not verified for this medication.Not verified for this medication.Not verified for this medication.Medication-specific control not yet verified.
ARCI Model RulesRacing model · Rules 15 / UCG 20.0 / CTMS 4.2.1
Conditions & sources

An unverified entry is not permission to use this medication. Consult the linked current rules. ARCI model comparison only; no state-specific rule is substituted. Schedule timing is tied to its stated regimen and is not a clearance guarantee.

UCG 20.0 PDF p. 45

Reviewed 2026-09-23

Not verified for this medication.Not verified for this medication.Not verified for this medication.Drug Class 5 · Penalty Class D. No dosing permission is implied by classification.
USEFNational Therapeutic Substance Provisions · 2026 + July amendment
Conditions & sources

An unverified entry is not permission to use this medication. Consult the linked current rules.

Reviewed 2026-09-23

Not verified for this medication.Not verified for this medication.Not verified for this medication.Medication-specific control not yet verified.